documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

382 rows where docket_id = "FDA-1976-N-0476" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, comment_start_date, comment_end_date, fr_doc_num, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1976-N-0476-0369 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Ross Herr (The Upjohn Company) and Dr. P. D. Lepore (FDA), dated 08/10/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:23:44Z   0 0 0900006480521a72
FDA-1976-N-0476-0595 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Internal Memorandum from Staff Scientist Bioresearch Monitoring Staff (HFC-30) to Dockets Management Branch (HFA-305), October 06, 1981 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:21:22Z   0 0 0900006480521b3d
FDA-1976-N-0476-0284 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Dr. John Farnham, American Cyanamid Company and Dr. Carl Schulz, FDA/BVM, dated 10/04/1978 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:41:11Z   0 0 0900006480521a1f
FDA-1976-N-0476-0275 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Dr. Ir. P. van der Wal, ILOB and Drs. M. A. Norcross and P. D. Lepore, FDA/BVM, dated 12/16/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:37:27Z   0 0 0900006480521a17
FDA-1976-N-0476-0316 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from National Association of Life Science Industries to FDA CVM Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:12:26Z   0 0 0900006480521a3e
FDA-1976-N-0476-0266 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. O. D. Butler and Dr. P. D. Lepore, FDA/BVM, dated 08/08/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:29:46Z   0 0 0900006480521a10
FDA-1976-N-0476-0323 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between The Upjohn Company and FDA/BVM, dated 03/13/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:15:55Z   0 0 0900006480521a44
FDA-1976-N-0476-0432 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Walter Gakenheimer (ICI America) and Dr. P. D. Lepore (FDA), dated 12/19/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T19:05:28Z   0 0 0900006480521aaa
FDA-1976-N-0476-0404 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between The Upjohn Company and FDA, dated 10/16/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:54:27Z   0 0 0900006480521a90
FDA-1976-N-0476-0394 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Patsy Marks (Dawson Laboratories) and Dr. Paul D. Lepore (FDA), dated 10/02/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:47:23Z   0 0 0900006480521a88
FDA-1976-N-0476-0370 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Lowell Irminger (Adria) and Dr. P. D. Lepore (FDA), dated 08/29/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:23:45Z   0 0 0900006480521a73
FDA-1976-N-0476-0399 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to Xybion Medical Systems Corporation Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:47:45Z   0 0 0900006483787852
FDA-1976-N-0476-0425 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Candy Prejean (Southern Research Institute) and Dr. Paul D. Lepore (FDA), dated 11/30/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:59:47Z   0 0 0900006480521aa4
FDA-1976-N-0476-0452 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to EG&G Mason Research Institute Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:12:47Z   0 0 090000648378c68f
FDA-1976-N-0476-0527 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. William Gray (Schering Corporation) and Dr. P. D. Lepore (FDA/ORA) May 8 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:47:55Z   0 0 0900006480521b03
FDA-1976-N-0476-0560 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from Dr. Paul D. Lepore, FDA to Robert S Gold, Metpath Inc Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:59:28Z   0 0 09000064837964ca
FDA-1976-N-0476-0555 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Patricia Richards (Fisonf Corporation) and Frank G. Pugliese (FDA/BVM), dated July 17 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:56:26Z   0 0 0900006480521b1c
FDA-1976-N-0476-0561 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Jean M Taylor, FDA to Ann Smith, Allied Chemical Company Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:00:08Z   0 0 0900006480521b21
FDA-1976-N-0476-0528 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Donald Howard (G. D. Searle and Company) and Dr. P. D. Lepore (FDA/ORA), dated 05/12/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:47:56Z   0 0 0900006480521b04
FDA-1976-N-0476-0601 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Good Laboratory Practices for Nonclinical Laboratory Studies; Public Hearing Notice Hearings 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z 1977-01-16T04:59:59Z 2019-01-30T21:21:54Z 76-36566 0 0 0900006480521b42
FDA-1976-N-0476-0563 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Fred Clark (A. H. Robins) and Dr. Paul D. Lepore (FDA/ORA) August 28 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:01:20Z   0 0 0900006480521b23
FDA-1976-N-0476-0568 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Paul Gittleson (Bristol Labs) and Dr. Paul D. Lepore (FDA/ORA) October 28 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:02:43Z   0 0 0900006480521b27
FDA-1976-N-0476-0503 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Nelson Ivans (Carter-Wallace Labs) and Dr. Paul D. Lepore (FDA/ORA), dated 03/19/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:36:54Z   0 0 0900006480521aec
FDA-1976-N-0476-0504 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between R. Holecek (Shell Development Corporation) and Dr. P. D. Lepore (FDA/ORA), dated 03/18/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:36:55Z   0 0 0900006480521aed
FDA-1976-N-0476-0483 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Virgil Place (Alza Corp) and Beth Anne Grove (FDA/BVM), dated 01/24/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:29:13Z   0 0 0900006480521ad9
FDA-1976-N-0476-0524 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Don MacKellor (Toxigenics, Inc.) and Dr. P. D. Lepore (FDA/ORA) April 18 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:45:04Z   0 0 0900006480521b01
FDA-1976-N-0476-0419 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Internal Memorandum from Steven S. Kuwahara, Bureau of Disease Control and Laboratory Services State of Michigan and Paul W. Goebel, Jr. (HFB-730) November 1, 1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:59:40Z   0 0 0900006480521a9e
FDA-1976-N-0476-0373 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Max Moeller (Bayvet Corporation) and Dr. Paul Lepore (FDA), dated 08/30/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:32:37Z   0 0 0900006480521a75
FDA-1976-N-0476-0351 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Petition for Stay of Action from The Pharmaceutical Manufacturers Association Other Petition for Reconsideration 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:55:05Z   0 0 0900006480521a61
FDA-1976-N-0476-0352 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. W. Gakenheimer, ICI Americas and Dr. Paul D. Lepore, FDA dated 06/21/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:55:06Z   0 0 0900006480521a62
FDA-1976-N-0476-0360 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to Objection from Dennis McKay Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:14:33Z   0 0 0900006483785c91
FDA-1976-N-0476-0303 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. T. S. Grafton, Natl. Soc. for Med. Research and Dr. P. D. Lepore, FDA/BVM dated 01/04/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:54:28Z   0 0 0900006480521a32
FDA-1976-N-0476-0307 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Leroy Schilt, Ralston Purina and Dr. P. D. Lepore, FDA/BVM dated 01/18/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:00:20Z   0 0 0900006480521a36
FDA-1976-N-0476-0321 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Drs. H. M. Peck and R. T. Drew, Merck Sharp & Dohme and Drs. D. Wagner and P. D. Lepore, FDA/BVM dated 03/08/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:15:52Z   0 0 0900006480521a42
FDA-1976-N-0476-0319 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Ralston Purina Co. and FDA/BVM, dated 02/07/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:15:49Z   0 0 0900006480521a40
FDA-1976-N-0476-0333 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Cynthia Sargent, Lederle Labs and Dr. P. D. Lepore, FDA dated 04/28/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:43:40Z   0 0 0900006480521a4f
FDA-1976-N-0476-0480 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Don McKuellar (Toxigenics, Inc) and Dr. P. D. Lepore (FDA/ORA), dated 01/30/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:25:22Z   0 0 0900006480521ad6
FDA-1976-N-0476-0556 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Sheldon Mazursky (Litton Bionetics) and Dr. Paul D. Lepore (FDA/ORA) July 25 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:56:27Z   0 0 0900006480521b1d
FDA-1976-N-0476-0502 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Julian Kramer and Dr. Paul D. Lepore (FDA/ORA), dated 03/19/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:36:53Z   0 0 0900006480521aeb
FDA-1976-N-0476-0469 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Supplement from Pharmaceutical Manufacturers Association Other Supplement (SUP) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:25:11Z   0 0 0900006480521aca
FDA-1976-N-0476-0574 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Jim Schaefer (Elars Bioresearch) and Dr. Paul D. Lepore (FDA) December 22 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:02:50Z   0 0 0900006480521b2d
FDA-1976-N-0476-0564 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between The Upjohn Company and FDA/ORA September 17 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:01:21Z   0 0 0900006480521b24
FDA-1976-N-0476-0565 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Jonas Bassen and Dr. P. D. Lepore (FDA/ORA) October 7 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:01:22Z   0 0 0900006480521b25
FDA-1976-N-0476-0341 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. M. Lovell, Lederle Laboratories and Dr. P. D. Lepore, FDA dated 05/22/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:45:43Z   0 0 0900006480521a57
FDA-1976-N-0476-0602 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Good Laboratory Practices for Nonclinical laboratory Studies, Public Hearing Extension Notice Hearings 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2020-01-31T06:56:46Z 77-3217 0 0 0900006483786fa1
FDA-1976-N-0476-0291 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Mr. Sheldon Mazursky, Litton Bionetics and Dr. David D. Wagner, FDA/BVM dated 01/15/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:42:57Z   0 0 0900006480521a26
FDA-1976-N-0476-0273 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between A. Fozard and A. Nelms, Mount Industrial Estate and M. A. Norcross and P. D. Lepore FDA/BVM dated 11/11/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:35:45Z   0 0 0900006480521a15
FDA-1976-N-0476-0279 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Dr. Benjamin H. Franklin, Dow Corning Corporation and Dr. Carl O Schulz, FDA/BVM, dated 06/01/1978 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:39:51Z   0 0 0900006480521a1a
FDA-1976-N-0476-0280 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Dr. George Schuppler, Dept. of Experimental Toxicology, and Drs. Paul Lepore et. al. FDA/BVM, dated 05/17/1978 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:39:52Z   0 0 0900006480521a1b
FDA-1976-N-0476-0309 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to Objection from Dr. Travis Griffin Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:00:28Z   0 0 090000648377a46e
FDA-1976-N-0476-0312 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Alan Hirsh, Ortho Pharmaceutical Corp. and Dr. P. D. Lepore, FDA/BVM dated 01/26/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:12:22Z   0 0 0900006480521a3a
FDA-1976-N-0476-0302 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Ms. Marion Vinegar, Hilltop Research and Dr. P. D. Lepore, FDA/BVM dated 01/04/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:54:27Z   0 0 0900006480521a31
FDA-1976-N-0476-0249 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Richard Morey, Kleinfeld, Kaplan, and Becker and Howard R. Roberts, FDA dated 04/12/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:23:32Z   0 0 0900006480521a02
FDA-1976-N-0476-0324 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Nonclinical Laboratory Studies, Good Laboratory Practice Regulations; Correction Rule Correction 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:15:55Z 79-9094 0 0 0900006480521a45
FDA-1976-N-0476-0322 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between T. J. Fogg, Shell and Dr. P. D. Lepore, FDA/BVM dated 03/12/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:15:53Z   0 0 0900006480521a43
FDA-1976-N-0476-0429 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Eva Zurek (Hazleton Laboratories) and Dr. P. D. Lepore (FDA), dated 12/11/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T19:02:08Z   0 0 0900006480521aa7
FDA-1976-N-0476-0363 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. R. Drew (Merck & Company) and Dr. P. D. Lepore (FDA), dated 08/03/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:18:32Z   0 0 0900006480521a6c
FDA-1976-N-0476-0401 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Nona Karten (Mason Research Institute) and Dr. P. D. Lepore (FDA), dated 10/11/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:52:30Z   0 0 0900006480521a8d
FDA-1976-N-0476-0248 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to Comment from Honorable Wendell R. Anderson, United States Senate Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:14:01Z   0 0 090000648374730d
FDA-1976-N-0476-0539 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Hall Moore (Burroughs-Wellcome) and Dr. P. D. Lepore (FDA/ORA) May 30 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:50:13Z   0 0 0900006480521b0e
FDA-1976-N-0476-0590 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to Bundesverband Der Pharmazeutischen Industrie E. V. Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:12:10Z   0 0 09000064837998a2
FDA-1976-N-0476-0598 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between The Upjohn Company and FDA/ORA February 22 1982 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:21:25Z   0 0 0900006480521b40
FDA-1976-N-0476-0576 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Dr. Thomas W. Orme (Toxicology Paperwork and Information, Inc.) and Dr. Paul D. Lepore (FDA) February 10 1981 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:02:52Z   0 0 0900006480521b2f
FDA-1976-N-0476-0505 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Art Uelner (Monsanto Corporation) and Dr. P. D. Lepore (FDA/ORA), dated 03/21/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:36:56Z   0 0 0900006480521aee
FDA-1976-N-0476-0345 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. E. C. Sadero, Intermedics and Dr. P. D. Lepore, FDA dated 06/05/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:45:47Z   0 0 0900006480521a5b
FDA-1976-N-0476-0338 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Internal Memorandum from Biological Scientist, Bioresearch Monitoring Staff (HFC-30) to Director Division of Field Investigations (HF0-500) May 21, 1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:45:40Z   0 0 0900006480521a54
FDA-1976-N-0476-0254 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum from James A. Peters, Division of Cancer Cause & Prevention, NCI to Associate Commissioner for Science, FDA Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:26:43Z   0 0 0900006480521a06
FDA-1976-N-0476-0311 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Ms. Laurie Ennis, Seller, Conner, & Cuneo and Dr. P. D. Lepore, FDA/BVM dated 01/29/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:12:21Z   0 0 0900006480521a39
FDA-1976-N-0476-0310 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Mr. Mike Hurley, Ayerst Laboratories and Dr. P. D. Lepore, FDA/BVM dated 01/23/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:12:20Z   0 0 0900006480521a38
FDA-1976-N-0476-0331 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Good Laboratory Practices Management Conferences Public Meeting Notice General Notice 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T17:41:31Z   0 0 0900006480521a4b
FDA-1976-N-0476-0551 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Nadine Drennan, Sanitation Laboratories to Paul D. Lepore, FDA Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:54:18Z   0 0 0900006480521b19
FDA-1976-N-0476-0535 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Ernest Brisson, FDA to Jose C. March, Guerlain, Inc. Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:49:00Z   0 0 0900006480521b0b
FDA-1976-N-0476-0523 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between ICI America and FDA/ORA April 18 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:45:03Z   0 0 0900006480521b00
FDA-1976-N-0476-0546 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from FDA to H. Lundbeck & Co. Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:52:11Z   0 0 09000064837953e4
FDA-1976-N-0476-0493 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. William D. Grey (Schering-Plough Corporation) and Dr. Paul D. Lepore (FDA/ORA), dated 02/25/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:36:45Z   0 0 0900006480521ae2
FDA-1976-N-0476-0497 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Lee Caldwell (G. D. Searle & Co.) and Dr. P. D. Lepore (FDA/ORA) dated 03/03/1980 and 03/04/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:36:49Z   0 0 0900006480521ae6
FDA-1976-N-0476-0562 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Dr. Paul D. Lepore to John J Gagliardi Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:01:19Z   0 0 0900006480521b22
FDA-1976-N-0476-0592 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Internal Memorandum from Bioresearch Monitoring Staff (HFC-30) to Dockets Management Branch (HFA-305) June 19, 1981 Supporting & Related Material Reference (internal unless indicated) 2019-01-30T05:00:00Z 2019 1     2019-01-30T21:12:48Z   0 0 0900006480521b3a
FDA-1976-N-0476-0400 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer from FDA to Letter from American Cyanimid Company Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:49:36Z   0 0 090000648378567d
FDA-1976-N-0476-0412 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Larry S. Isacson of Beckman Instruments, Inc. to Paul Lepore of FDA Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:56:26Z   0 0 0900006480521a98
FDA-1976-N-0476-0423 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Candy Prejean (Southern Research Institute) and Dr. P. D. Lepore (FDA), dated 11/28/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:59:45Z   0 0 0900006480521aa2
FDA-1976-N-0476-0417 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Carnegie-Mellon Institute of Research to FDA Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:58:23Z   0 0 0900006480521a9c
FDA-1976-N-0476-0377 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Nelson Ivins (09/07/1979) and Dr. P. D. Lepore (FDA), dated 09/07/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:32:40Z   0 0 0900006480521a79
FDA-1976-N-0476-0375 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from FDA to Borriston Research Laboratories Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:32:39Z   0 0 0900006480521a77
FDA-1976-N-0476-0371 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Microscopy for Biological Research, Ltd. to FDA Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:23:46Z   0 0 0900006480521a74
FDA-1976-N-0476-0361 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Charles Rayner (Miles Laboratories) and Dr. P. D. Lepore (FDA), dated 07/12/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T18:18:30Z   0 0 0900006480521a6a
FDA-1976-N-0476-0451 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from EG. and G. Mason Research Institute to FDA Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:10:00Z   0 0 0900006480521aba
FDA-1976-N-0476-0437 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Letter from Paul D. Lepore, FDA to Robert Broyles, Ralston-Purina Company Other Letter(s) 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T19:07:11Z   0 0 0900006480521aae
FDA-1976-N-0476-0257 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Drs. Sanford Berman and Dr. Howard Lowensohn, Walter Reed Institute of Research and Dr. P. D. Lepore FDA/CVM dated 06/16/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:26:46Z   0 0 0900006480521a09
FDA-1976-N-0476-0265 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting Between ICI USA, ICI UK and FDA BVM, dated 07/07/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:29:45Z   0 0 0900006480521a0f
FDA-1976-N-0476-0288 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum from Paul D. Lepore, FDA/BVM to Dr. L. Schilt, Ralston Purina Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:42:55Z   0 0 0900006480521a23
FDA-1976-N-0476-0269 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Dr. Erwig Pinter, BPI and Drs. Paul D. Lepore and Carl O. Schulz FDA/BVM, dated 09/20/1977 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:31:49Z   0 0 0900006480521a12
FDA-1976-N-0476-0298 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Paul Kraus, Allergan and Dr. P. D. Lepore, FDA/BVM dated 01/03/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:54:22Z   0 0 0900006480521a2d
FDA-1976-N-0476-0294 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Mr. Mike McCulley, Am. Hospital Supply Company and Dr. P. D. Lepore, FDA/BVM dated 01/05/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:43:00Z   0 0 0900006480521a29
FDA-1976-N-0476-0315 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Meeting between Allied Mills, Inc. and FDA/BVM dated 02/16/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T15:12:25Z   0 0 0900006480521a3d
FDA-1976-N-0476-0289 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Mr. Sheldon Mazursky, Litton Bionetics and Dr. David Wagner, FDA/BVM dated 01/08/1979 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T14:42:56Z   0 0 0900006480521a24
FDA-1976-N-0476-0594 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Internal Memorandum from Dr. Paul D. Lepore (HFC-30) to Dockets Management Branch (HFA-305), August 14,1981 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T21:21:21Z   0 0 0900006480521b3c
FDA-1976-N-0476-0487 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Dr. Jim Richmond (Ciba-Geigy) and Dr. Paul D. Lepore (FDA/ORA), dated 02/07/1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:29:16Z   0 0 0900006480521add
FDA-1976-N-0476-0552 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Answer Letter from Paul D. Lepore, FDA to Nadine Drennan, Sanitation Laboratories Other Answer 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:55:00Z   0 0 0900006483795bec
FDA-1976-N-0476-0518 FDA Good Laboratory Practice for Nonclinical Laboratory Studi- Open FDA-1976-N-0476 Memorandum of Telephone Conversation between Huntingdon Research Centre and FAD/ORA April 28 1980 Other Memorandum 2019-01-30T05:00:00Z 2019 1 2019-01-30T05:00:00Z   2019-01-30T20:44:59Z   0 0 0900006480521afb

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);